ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.690,92
0,05%
S&P 500
5.307,01
-0,27%
Dow Jones
39.671,04
-0,51%
Euro vs US Dollar
1,08392
0,13%
Bitcoin
69.719,40
0,89%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Baxter International Inc (BAX)

  7. Baxter International Inc (BAX) News

BAX

Baxter (BAX)

Baxter International Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:BAX
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202420h42Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNYSE:BAXBaxter International Inc
15/05/202420h00Business WireBaxter Announces Mission and Logo for Proposed Kidney Care Company VantiveNYSE:BAXBaxter International Inc
13/05/202414h45Business WireBaxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric IndicationNYSE:BAXBaxter International Inc
09/05/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
09/05/202422h27Edgar (US Regulatory)Form 8-K - Current reportNYSE:BAXBaxter International Inc
07/05/202422h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:BAXBaxter International Inc
07/05/202422h15Business WireBaxter to Present at Bank of America 2024 Health Care ConferenceNYSE:BAXBaxter International Inc
07/05/202414h30Business WireBaxter Declares Quarterly DividendNYSE:BAXBaxter International Inc
02/05/202413h15Business WireBaxter Reports First-Quarter 2024 ResultsNYSE:BAXBaxter International Inc
11/04/202414h30Business WireBaxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.NYSE:BAXBaxter International Inc
10/04/202422h15Business WireBaxter to Host First-Quarter 2024 Financial Results Conference Call for InvestorsNYSE:BAXBaxter International Inc
01/04/202413h15Business WireBaxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion TherapyNYSE:BAXBaxter International Inc
27/03/202414h00Business WireBaxter to Host Annual Meeting of Stockholders in Virtual FormatNYSE:BAXBaxter International Inc
08/03/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
08/03/202422h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BAXBaxter International Inc
 Showing the most relevant articles for your search:NYSE:BAX

Kürzlich von Ihnen besucht

GDAX
CRVEUR
Curve DAO Token
HUOB
NESTUSDT
NEST
BIT
F16736
Vontobel Financial Produ...
USOTC
VITOF
Vitro Sa Mexico (CE)
USOTC
SGMCF
Sagen MI CDA (GM)
ASX
STWDO2
NASDAQ
MUDS
Mudrick Capital Acquisit...
ASX
ADYN
ASX
TPC
TPC Consolidated
BIT
1SHL
Siemens Healthineers
NASDAQ
LGMEAX
L&G MSCI EAFE CIT
USOTC
TOLWF
Trican Well Service (PK)
LSE
IRGP
ASX
HSXKOV
TSX
TRI.PR.B
Thomson Reuters
EU
1209T
1209T
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten